As of 2025-02-13, the Relative Valuation of Harvard Bioscience Inc (HBIO) is (9.70) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.31 USD, the upside of Harvard Bioscience Inc based on Relative Valuation is -840.8%.
The range of the Relative Valuation is (9.38) - (10.06) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 28.7x - 33.4x | 31.6x |
Forward P/E multiples | 26.2x - 30.8x | 27.9x |
Fair Price | (9.38) - (10.06) | (9.70) |
Upside | -815.8% - -868.1% | -840.8% |
Date | P/E |
2025-02-07 | -4.41 |
2025-02-06 | -4.53 |
2025-02-05 | -5.08 |
2025-02-04 | -5.12 |
2025-02-03 | -5.05 |
2025-01-31 | -5.24 |
2025-01-30 | -5.42 |
2025-01-29 | -5.36 |
2025-01-28 | -5.24 |
2025-01-27 | -5.51 |
2025-01-24 | -5.33 |
2025-01-23 | -5.64 |
2025-01-22 | -5.97 |
2025-01-21 | -5.97 |
2025-01-17 | -5.91 |
2025-01-16 | -5.88 |
2025-01-15 | -6.06 |
2025-01-14 | -6.19 |
2025-01-13 | -6.06 |
2025-01-10 | -5.82 |
2025-01-08 | -6.59 |
2025-01-07 | -6.59 |
2025-01-06 | -6.71 |
2025-01-03 | -6.55 |
2025-01-02 | -6.22 |
2024-12-31 | -6.46 |
2024-12-30 | -6.19 |
2024-12-27 | -6.06 |
2024-12-26 | -6.43 |
2024-12-24 | -6.37 |
2024-12-23 | -6.43 |
2024-12-20 | -6.46 |
2024-12-19 | -6.43 |
2024-12-18 | -6.22 |
2024-12-17 | -6.65 |
2024-12-16 | -6.55 |
2024-12-13 | -6.62 |
2024-12-12 | -6.86 |
2024-12-11 | -7.11 |
2024-12-10 | -7.17 |
2024-12-09 | -7.14 |
2024-12-06 | -6.92 |
2024-12-05 | -6.55 |
2024-12-04 | -6.92 |
2024-12-03 | -6.86 |
2024-12-02 | -6.74 |
2024-11-29 | -6.74 |
2024-11-27 | -6.74 |
2024-11-26 | -6.71 |
2024-11-25 | -6.86 |